Bohn, Barbara <br/><br/>
[Which patients from routine care use the new insulin analogue glargine U300 compared to patients with glargine U100 : A multicenter analysis of 14,123 patients with insulin glargine from die diabetes registries DPV and DIVE].  [electronic resource] 

 -  Wiener medizinische Wochenschrift (1946)  Nov 2018 
 - 415-422 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1563-258X 
<br/><br/><label>Standard No.: </label>10.1007/s10354-017-0589-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Austria<br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Germany<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin Glargine--therapeutic use<br/>Male<br/>Middle Aged<br/>Registries<br/>Treatment Outcome<br/>Young Adult